Cargando…
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Pyrazinamide (PZA) is a frontline anti-tuberculosis drug that plays a crucial role in the treatment of both drug susceptible and multidrug-resistant tuberculosis (MDR-TB). Resistance to PZA is most commonly associated with mutations in the pncA gene encoding nicotinamidase/pyrazinamidase which conve...
Autores principales: | Zhang, Shuo, Chen, Jiazhen, Shi, Wanliang, Liu, Wei, Zhang, Wenhong, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697303/ https://www.ncbi.nlm.nih.gov/pubmed/26038471 http://dx.doi.org/10.1038/emi.2013.38 |
Ejemplares similares
-
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
por: Shi, Wanliang, et al.
Publicado: (2014) -
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
por: Sun, Qingan, et al.
Publicado: (2020) -
Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2017) -
PanM, an Acetyl-Coenzyme A Sensor Required for Maturation of l-Aspartate Decarboxylase (PanD)
por: Stuecker, Tara N., et al.
Publicado: (2012) -
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense
Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1
por: Gopal, Pooja, et al.
Publicado: (2017)